Samsung Healthcare Unveils Innovations in Radiography and Ultrasound at RSNA 2026

Samsung Healthcare is set to showcase its latest innovations in radiography and ultrasound at the 2026 Radiological Society of North America (RSNA) Annual Meeting. The highlight will be the introduction of the new GC85A Fit radiography system and significant advancements in its ultrasound offerings.

The GC85A Fit represents an expansion of Samsung’s radiography portfolio with a semi-automated, ceiling-mounted design tailored for emergency and trauma departments, orthopedic practices, and general radiography environments. This system features intuitive workflows and delivers high-quality imaging, thereby enhancing efficient daily examinations and diagnostic confidence. Its flexible configurations and adaptable design cater to a variety of room layouts and operational requirements, making it a sound investment for healthcare facilities aiming to upgrade their imaging capabilities while accommodating future growth.

Jeyul Chang, Head of Sales & Marketing Team, Health & Medical Equipment Business at Samsung Electronics, emphasized the importance of understanding customer needs in driving innovation at Samsung. He remarked, "The GC85A Fit reflects this approach, combining high-quality imaging with greater flexibility and workflow efficiency across diverse clinical environments."

In addition to the GC85A Fit, Samsung has achieved a milestone by standardizing its ultrasound portfolio under a common software architecture, allowing for a consistent experience across different systems. This uniformity is designed to minimize training time for sonographers and radiologists who may work on various machines at different sites. The shared software framework also facilitates faster development and integration of new technologies throughout the portfolio, with Windows 11 and advanced computing architecture enhancing cybersecurity and AI scalability.

At the RSNA 2026, Samsung will present the new X10 tablet ultrasound system, noted for its streamlined workflows and battery-powered mobility. Additionally, upgrades to the R20 ultrasound platform will feature AI-powered Deep USFF for liver fat quantification and viscosity imaging, designed to support non-invasive assessment and management of liver disease. The exhibit will also include new AI Assist tools aimed at improving exam efficiency and clinical productivity.

Tracy Bury, Chief Commercial Officer of Samsung Healthcare USA, stated, "Healthcare organizations shouldn't have to choose between advanced imaging technology and responsible capital investment. We are delivering innovative solutions that adapt to the needs of healthcare providers and the clinical demands of their environments."

Samsung’s mobile CT portfolio will also be on display, showcasing the BodyTom 64, which combines battery-powered scanning with mobility across care settings. Its 85 cm bore and independent workstation enhance workflow efficiency. The OmniTom PCD utilizes photon-counting detector technology for high-resolution imaging with reduced radiation doses.